查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018487

磁振造影血管血管造影术市场：依产品、磁场强度、技术、应用和最终用户划分－2026-2032年全球市场预测

Magnetic Resonance Angiography Market by Product, Field Strength, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，磁振造影血管造影术(MRA) 市值将达到 35.6 亿美元，到 2026 年将成长至 39.2 亿美元，到 2032 年将达到 76.7 亿美元，复合年增长率为 11.57%。

主要市场统计数据
基准年 2025 35.6亿美元
预计年份：2026年 39.2亿美元
预测年份 2032 76.7亿美元
复合年增长率 (%) 11.57%

本文简要概述了磁振造影血管造影术(MRA) 的最新创新如何与临床需求、营运重点和组织决策相交。

磁振造影血管血管造影术（MRA）处于影像创新与血管治疗路径的关键交会点，为临床医师在各种临床环境中提供非侵入性的血管可视化手段。近年来，技术的进步降低了操作的复杂性，拓展了其临床应用范围，并提高了患者的舒适度，使MRA从小众影像技术发展成为许多血管治疗流程中的核心诊断工具。这些进步得益于定序技术的创新、硬体的进步以及软体驱动的影像重建，它们重新定义了临床医生的期望和采购重点。

对正在重新定义磁振造影血管造影术的实践和实施的硬体、定序和计算技术趋势进行详细分析。

在磁振造影血管摄影（MRA）领域，硬体、脉衝序列设计和计算影像处理的进步融合正在带来变革性的转变。高场系统不断突破信噪比的极限，实现更高的空间解析度；同时，低场系统的同步发展也因其整体拥有成本更低、更易于操作等优势而重新引起人们的关注。此外，诸如飞行时间法和静止间隔单次激发法等造影剂技术日益成熟，减少了对钆基造影剂的依赖，并重塑了肾功能不全患者和需要重复成像患者的临床方案。

评估美国 2025 年的新关税措施将如何影响整个磁振造影血管造影术(MRA) 生态系统的筹资策略、供应链和资本规划。

美国2025年实施的新关税将为互认协议（MRA）的相关人员带来复杂的环境，影响采购週期、采购决策和供应商关係。关税带来的成本压力可能会推高进口零件和完整影像系统的到货价格，进而影响医院、诊断中心和门诊机构的资金配置和升级计画。面对不断上涨的采购成本，许多买家可能会推迟升级，或优先考虑可分阶段实施的模组化投资。同时，一些买家可能会更仔细地审查总拥有成本（TCO），包括维护和耗材供应合约。

详细的細項分析揭示了产品类型、市场规模层级、影像技术、临床应用和最终用户概况如何全面影响 MRA 的需求和投资。

对市场区隔的深入理解揭示了临床需求和投资在整个磁振造影血管摄影（MRA）市场的交汇点。依产品分析市场，可以清楚看到配件、耗材、持续服务合约和资本设备系统之间的价值流动。系统本身也分为高场强和低场强平台，每个平台都提供不同的临床功能和生命週期经济效益。即使仅按场强进行细分，这种二分性也同样存在，高场强和低场强平台分别对应不同的临床应用场景和医疗预算。基于技术的细分錶明，造影增强方法与相位对比调查方法、静态间隔单次成像和飞行时间成像并存，每种方法都具有独特的诊断优势和特定的序列工作流程要求。

一项全面的区域分析，显示了美洲、欧洲、中东和非洲以及亚太地区在MRA的采用模式、采购趋势和临床重点方面的差异。

区域趋势对全球MRA市场整体影响显着，进而影响技术应用、报销机制与临床实务模式。在美洲，临床网路和大规模医疗系统往往推动高效能係统和先进定序文库的早期应用，而支付方模式和医院资金筹措方式的差异则导致采购节奏的显着差异。欧洲、中东和非洲既有成熟的市场（拥有完善的报销机制），也有新兴的医疗系统（优先考虑成本效益高且扩充性的解决方案）。监管协调和跨境临床合作的努力进一步塑造了这些地区的需求。在亚太地区，都市区的应用速度很快，这得益于诊断基础设施的扩展和对非侵入性血管诊断投资的增加。然而，高所得大都会圈和资源匮乏地区之间的市场成熟度差异很大，在资源匮乏地区，低场系统和更有效率的服务模式可能更具实用性。

一项策略性竞争分析，重点在于决定磁振造影血管血管造影术(MRA) 市场供应商成功的整合硬体、软体和服务提案。

在磁振造影血管摄影（MRA）生态系统中，竞争格局的格局正日益不再取决于单一设备的销售，而是取决于整合硬体、定序库、后处理软体和服务合约的整合解决方案。能够为系统提供强大的软体工具包（用于血管分割、血流定量和人工智慧增强重建）的原始设备製造商（OEM）正在大规模医疗保健系统中占据更有利的地位，这些系统优先考虑互通性和清晰的蓝图。同时，专注于耗材、线圈和手术配件的供应商则在临床适用性、易于整合性和可预测的供应链方面竞争。提供快速维护、远距离诊断和灵活培训计划的服务供应商正在为寻求正常运作和提升员工能力的终端使用者创造实际价值。

为产业领导者提供实用的策略框架，以优化 MRA 解决方案的技术投资、供应链、临床检验和商业化。

产业领导者应采取多管齐下的策略，加速在所有医疗机构推广MRA技术，同时提升临床价值并降低外部风险。首先，应优先投资于定序和软体开发，以显着缩短扫描时间并提高诊断可靠性，从而增强临床投资回报率。同时，应实现供应链多元化，并探索区域製造或组装伙伴关係关係，以降低关税风险并缩短前置作业时间。这些营运措施应辅以灵活的经营模式，将资本投资与基本服务和软体收入脱钩，为采购者提供符合其预算和临床安排的客製化选择。

我们将以透明的方式解释我们的混合方法研究方法，该方法结合了第二手资料审查、一手访谈和严格的检验，以确保对MRA有可靠的见解。

本研究整合了透过混合方法收集的研究结果，该方法强调三角检验和相关人员核实。次要分析包括对同行评审的临床文献、技术白皮书、监管申报文件和公共采购文件进行系统性回顾，揭示了序列开发、磁场强度利用和临床实践的趋势。主要研究包括对客观选取的放射科医生、血管外科医生、放射技师、医院采购负责人和影像服务提供者的高级管理人员进行结构化访谈和讨论，以确保涵盖临床、营运和商业领域的多元化观点。

技术、临床和操作因素的整合将决定磁振造影血管造影术（MRA）能否实现更广泛的临床整合和永续的价值创造。

磁振造影血管血管造影术（MRA）正处于技术创新、临床需求和经济压力交会的十字路口。高场和低场系统的进步、无造影和造影增强技术的改进以及人工智慧重建技术的整合，正在拓展该技术的临床应用范围。同时，费用调整、供应链重组和区域采购条件等结构性因素正在重塑各机构实施和部署MRA功能的方式。这些双重力量既为价值创造提供了机会，也使得策略调整至关重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 磁振造影血管血管造影术市场：依产品分类

  • 配件和耗材
  • 服务
  • 系统
    • 高磁场强度系统
    • 低磁场强度系统

第九章：以磁场强度分類的磁振造影血管造影术市场

  • 高磁场强度
  • 低磁场强度

第十章 磁振造影血管血管造影术市场：依技术划分

  • 造影的使用
  • 相衬
  • 单次射击，休息间隔
  • 飞行时间法

第十一章 磁振造影血管血管造影术市场：依应用领域划分

  • 心血管系统
  • 神经血管
  • 週边血管

第十二章 磁振造影血管血管造影术市场：依最终用户划分

  • 学术研究机构
  • 门诊手术中心
  • 诊断影像中心
  • 医院

第十三章 磁振造影血管血管造影术市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 磁振造影血管血管造影术市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 磁振造影血管血管造影术市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国磁振造影血管造影术市场

第十七章：中国磁振造影血管造影术市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ASG Superconductors SpA
  • Aspect Imaging Ltd.
  • Aurora Imaging Technologies, Inc.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Esaote SpA
  • Fonar Corporation
  • Fujifilm Holdings Corporation
  • GE Healthcare, Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Hyperfine, Inc.
  • Koninklijke Philips NV
  • Neusoft Medical Systems Co., Ltd.
  • Oxford Instruments plc
  • Samsung Medison Co., Ltd.
  • Shenzhen Anke High-tech Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Time Medical Holding Co., Ltd.
  • United Imaging Healthcare Co., Ltd.
  • Wandong Medical Equipment Co., Ltd.
Product Code: MRR-A339DAEFA1A0

The Magnetic Resonance Angiography Market was valued at USD 3.56 billion in 2025 and is projected to grow to USD 3.92 billion in 2026, with a CAGR of 11.57%, reaching USD 7.67 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.56 billion
Estimated Year [2026] USD 3.92 billion
Forecast Year [2032] USD 7.67 billion
CAGR (%) 11.57%

Concise framing of how modern magnetic resonance angiography innovations intersect with clinical needs, operational priorities, and organizational decision-making

Magnetic resonance angiography (MRA) occupies a critical nexus between diagnostic imaging innovation and vascular care pathways, offering clinicians noninvasive visualization of blood vessels across a spectrum of clinical settings. Recent technological progress has reduced procedural complexity, expanded clinical indications, and improved patient comfort, thereby elevating MRA from a niche modality to a pivotal diagnostic tool in many vascular workflows. These developments, driven by sequence innovation, hardware evolution, and software-enabled image reconstruction, have reshaped clinician expectations and procurement priorities.

Consequently, stakeholders across imaging departments, clinical research units, and device manufacturing must reassess how MRA integrates with broader diagnostic strategies. Radiology teams are increasingly prioritizing throughput and diagnostic confidence, while hospital administrators seek modalities that support multi-disciplinary uses and predictable lifecycle costs. At the same time, ambulatory centers and diagnostic imaging providers are evaluating how MRA can enhance service portfolios without imposing unsustainable operational burdens. This introduction situates MRA within the contemporary clinical and commercial landscape, emphasizing the interplay between technological capability, clinical uptake, and organizational decision-making.

Detailed exploration of the converging hardware, sequence, and computational trends that are redefining magnetic resonance angiography practice and procurement

The MRA landscape is experiencing transformative shifts driven by converging advances in hardware, pulse-sequence design, and computational imaging. High-field systems continue to push signal-to-noise boundaries and enable higher spatial resolution, yet parallel progress in low-field systems has revived interest due to cost-of-ownership advantages and improved accessibility. Simultaneously, non-contrast techniques such as time-of-flight and quiescent interval single shot have matured to reduce reliance on gadolinium-based agents, reshaping clinical protocols for patients with renal impairment and those requiring repeated imaging.

In parallel, phase contrast sequences and advanced contrast-enhanced methods have been refined for hemodynamic assessments, facilitating more nuanced evaluation of vascular flow and lesion characterization. Artificial intelligence and machine learning now play an increasingly central role in reconstruction, denoising, and automated vessel segmentation, shortening scan times and enhancing diagnostic yield. As a result, service models and consumable workflows are adapting to support hybrid offerings that combine high-end systems, optimized sequence libraries, and value-added software. These shifts collectively redefine procurement criteria and clinical pathways, making interoperability, upgradeability, and software licensing as influential as baseline hardware specifications.

Assessment of how new 2025 tariff measures in the United States are reshaping procurement strategies, supply chains, and capital planning across the magnetic resonance angiography ecosystem

The introduction of new tariffs in the United States in 2025 creates a complex environment for MRA stakeholders, affecting procurement cycles, sourcing decisions, and supplier relationships. Tariff-related cost pressures can raise the landed price of imported components and finished imaging systems, which in turn influences capital allocation and replacement timelines for hospitals, diagnostic centers, and ambulatory facilities. Faced with higher acquisition costs, many purchasers may defer upgrades or prioritize modular investments that can be staged over time, while others will scrutinize total cost of ownership more intensely, including maintenance contracts and consumable supply agreements.

Furthermore, tariff policies incentivize strategic supplier diversification and nearshoring, prompting manufacturers to reconfigure supply chains to mitigate exposure to tariff volatility. For service providers and consumable suppliers, tariffs may alter competitive dynamics as local production becomes relatively more attractive. In this context, procurement teams and clinical leaders must factor supply chain resilience into sourcing criteria, balancing potential short-term cost savings against the risks of single-source dependencies. Regulatory compliance and customs optimization will therefore assume greater importance, and stakeholders should be prepared to engage suppliers on inventory planning and contract flexibility to absorb episodic tariff impacts. Taken together, these adjustments will shape capital planning, vendor negotiations, and operational continuity throughout the imaging ecosystem.

In-depth segmentation synthesis revealing how product types, field strength tiers, imaging technologies, clinical applications, and end-user profiles collectively shape MRA demand and investment

A granular understanding of market segmentation illuminates where clinical demand and investment converge across the MRA landscape. When the market is parsed by product, distinct value streams emerge between accessories and consumables, ongoing service arrangements, and capital systems, with systems themselves bifurcating into high field strength and low field strength platforms that deliver different clinical capabilities and lifecycle economics. This dichotomy is mirrored when segmentation is organized by field strength alone, as high field strength and low field strength platforms each address separate clinical use cases and institutional budgets. Technology-based segmentation reveals how Contrast Enhanced procedures coexist alongside Phase Contrast methodologies, Quiescent Interval Single Shot techniques, and Time Of Flight approaches, each contributing unique diagnostic strengths and sequence-specific workflow requirements.

Application-focused segmentation further clarifies clinical trajectories, with cardiovascular applications encompassing both aortic and cardiac imaging needs, neurovascular practice differentiating between extracranial and intracranial indications, and peripheral vascular use cases delineating imaging of lower limb and upper limb territories. These clinical partitions interact with end-user categories, including academic research institutes, ambulatory surgical centers, diagnostic imaging centers, and hospitals, which vary markedly in procurement cycles, clinical throughput expectations, and staffing models. Consequently, product, field strength, technology, application, and end-user segments create overlapping demand pockets; by tracing these intersections, stakeholders can prioritize investments, tailor service offerings, and design clinical validation studies that resonate with the operational realities of each segment.

Comprehensive regional analysis showing how Americas, Europe Middle East & Africa, and Asia-Pacific each present distinct adoption patterns, procurement dynamics, and clinical priorities for MRA

Regional dynamics exert a profound influence on technology adoption, reimbursement frameworks, and clinical practice patterns across the global MRA landscape. In the Americas, clinical networks and large health systems often drive early adoption of high-performance systems and advanced sequence libraries, while variations in payer models and hospital funding introduce distinct procurement rhythms. Europe, Middle East & Africa present a heterogeneous mix of mature markets with established reimbursement pathways alongside emerging healthcare systems that prioritize cost-effective, scalable solutions; regulatory harmonization efforts and cross-border clinical collaborations further shape demand in these territories. Asia-Pacific exhibits rapid uptake in urban centers driven by expanding diagnostic infrastructures and increasing investment in noninvasive vascular diagnostics, yet market maturation varies widely between high-income metropolitan areas and resource-constrained regions where low-field systems and streamlined service models may be more practical.

Across these geographies, differences in clinical guidelines, training pipelines, and service delivery models influence how MRA is positioned relative to alternative imaging modalities. Vendors and service providers should therefore adopt region-specific engagement strategies that account for procurement cycles, local clinical champions, and regional regulatory considerations. Moreover, partnerships with regional research institutions and targeted clinical education programs can accelerate adoption where clinical demand and capacity align, while flexible commercial models can help bridge gaps in regions with constrained capital availability.

Strategic competitive analysis highlighting how integrated hardware, software, and service propositions determine vendor success in magnetic resonance angiography markets

Competitive dynamics in the MRA ecosystem are increasingly defined by integrated offerings that combine hardware, sequence libraries, post-processing software, and service contracts rather than standalone equipment sales. Original equipment manufacturers who can complement systems with robust software toolkits for vessel segmentation, flow quantification, and AI-enhanced reconstruction secure stronger footholds among large health systems that prize interoperability and roadmap clarity. Simultaneously, specialist vendors focused on consumables, coils, and procedural accessories compete on the basis of clinical compatibility, ease of integration, and predictable supply chains. Service providers that deliver responsive maintenance, remote diagnostics, and flexible training programs add tangible value for end users seeking uptime assurance and staff competency.

Strategic partnerships between imaging IT providers and clinical networks are also emerging as a differentiator, enabling longitudinal data analytics and quality improvement initiatives that extend the clinical utility of MRA. In this environment, companies that invest in clinical validation, provide transparent upgrade paths, and demonstrate strong regulatory compliance are better positioned to win complex, multi-stakeholder procurement decisions. For smaller firms, focusing on niche clinical applications, compelling economic value propositions, or novel contrast and non-contrast techniques can create defensible market positions. Ultimately, success rests on aligning product and service innovations with the operational realities of diverse clinical environments while managing supply chain and tariff-related risks through adaptive sourcing strategies.

Actionable strategic framework for industry leaders to optimize technology investments, supply chains, clinical validation, and commercialization of MRA solutions

Industry leaders should pursue a multi-pronged strategy to capture clinical value and mitigate external risks while accelerating MRA adoption across care settings. First, prioritize investments in sequence and software development that materially reduce scan time and enhance diagnostic confidence, enabling stronger clinical ROI narratives. Concurrently, diversify supply chains and explore regional manufacturing or assembly partnerships to buffer tariff exposure and improve lead times. These operational moves should be complemented by flexible commercial models that decouple capital acquisition from essential service and software revenues, giving purchasers options that align with their budget and clinical schedules.

Second, cultivate clinical evidence through targeted validation studies that demonstrate comparative performance across key use cases such as aortic imaging, cardiac vascular assessment, intracranial lesion characterization, and peripheral limb evaluation. Third, invest in training and change management programs to ensure radiology teams and technologists can extract maximum diagnostic value from new sequences and AI-based tools. Fourth, develop region-specific go-to-market plans that reflect reimbursement realities, regulatory nuances, and the varying adoption curves of high field versus low field systems. Finally, engage proactively with payers, health systems, and clinical societies to articulate the clinical and economic value of MRA-based pathways, thereby creating a supportive environment for sustainable adoption and scale.

Transparent description of the mixed-methods research approach combining secondary review, primary interviews, and rigorous validation to ensure reliable MRA insights

This research synthesizes insights gathered through a mixed-methods approach that emphasizes triangulation and stakeholder validation. Secondary analysis included a systematic review of peer-reviewed clinical literature, technical whitepapers, regulatory filings, and public procurement documentation to establish trends in sequence development, field strength utilization, and clinical practice. Primary research comprised structured interviews and consultations with a purposive sample of radiologists, vascular surgeons, imaging technologists, hospital procurement officers, and senior executives from imaging providers, ensuring diverse perspectives across clinical, operational, and commercial domains.

Quantitative and qualitative data were integrated through thematic coding and comparative analysis, with particular attention paid to sequence performance metrics, operational constraints, and purchasing considerations. Findings were validated through follow-up discussions with clinical and procurement stakeholders to confirm practical relevance and to calibrate interpretations against real-world workflows. Throughout the process, care was taken to anonymize primary-source inputs and to document methodological assumptions, enabling reproducibility and transparency. Limitations and potential biases are acknowledged, and areas identified for further primary study are noted to guide subsequent research investments.

Synthesis of technological, clinical, and operational factors that will determine whether magnetic resonance angiography achieves broader clinical integration and sustained value creation

Magnetic resonance angiography sits at an inflection point where technical innovation, clinical demand, and economic pressures converge. Advancements in both high-field and low-field systems, refinements in non-contrast and contrast-enhanced techniques, and the integration of AI-driven reconstruction are collectively expanding the modality's clinical applicability. At the same time, structural factors such as tariff changes, supply chain reconfiguration, and regional procurement idiosyncrasies are reshaping how organizations acquire and deploy MRA capabilities. These dual forces create both opportunities for value creation and imperatives for strategic adaptation.

Looking ahead, stakeholders that align product development with demonstrable clinical outcomes, maintain flexible sourcing strategies, and invest in clinician training will be best positioned to translate technological potential into routine clinical benefit. Cross-disciplinary collaboration between device manufacturers, clinical teams, and imaging IT providers will accelerate the realization of advanced vascular diagnostics in everyday practice. In short, MRA's future will be defined not only by imaging performance but also by the capacity of the ecosystem to deliver accessible, reliable, and clinically integrated solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Magnetic Resonance Angiography Market, by Product

  • 8.1. Accessories And Consumables
  • 8.2. Service
  • 8.3. Systems
    • 8.3.1. High Field Strength System
    • 8.3.2. Low Field Strength System

9. Magnetic Resonance Angiography Market, by Field Strength

  • 9.1. High Field Strength
  • 9.2. Low Field Strength

10. Magnetic Resonance Angiography Market, by Technology

  • 10.1. Contrast Enhanced
  • 10.2. Phase Contrast
  • 10.3. Quiescent Interval Single Shot
  • 10.4. Time Of Flight

11. Magnetic Resonance Angiography Market, by Application

  • 11.1. Cardiovascular
  • 11.2. Neurovascular
  • 11.3. Peripheral Vascular

12. Magnetic Resonance Angiography Market, by End User

  • 12.1. Academic Research Institute
  • 12.2. Ambulatory Surgical Center
  • 12.3. Diagnostic Imaging Center
  • 12.4. Hospital

13. Magnetic Resonance Angiography Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Magnetic Resonance Angiography Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Magnetic Resonance Angiography Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Magnetic Resonance Angiography Market

17. China Magnetic Resonance Angiography Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ASG Superconductors S.p.A.
  • 18.6. Aspect Imaging Ltd.
  • 18.7. Aurora Imaging Technologies, Inc.
  • 18.8. Bruker Corporation
  • 18.9. Canon Medical Systems Corporation
  • 18.10. Esaote S.p.A.
  • 18.11. Fonar Corporation
  • 18.12. Fujifilm Holdings Corporation
  • 18.13. GE Healthcare, Inc.
  • 18.14. Hitachi, Ltd.
  • 18.15. Hologic, Inc.
  • 18.16. Hyperfine, Inc.
  • 18.17. Koninklijke Philips N.V.
  • 18.18. Neusoft Medical Systems Co., Ltd.
  • 18.19. Oxford Instruments plc
  • 18.20. Samsung Medison Co., Ltd.
  • 18.21. Shenzhen Anke High-tech Co., Ltd.
  • 18.22. Shimadzu Corporation
  • 18.23. Siemens Healthineers AG
  • 18.24. Time Medical Holding Co., Ltd.
  • 18.25. United Imaging Healthcare Co., Ltd.
  • 18.26. Wandong Medical Equipment Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 129. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 130. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 131. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 150. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 151. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 152. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 157. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 158. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 159. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)